RxDoctor Payments Data

Daniel Rubio, MD

Orthopaedic Surgery of the Spine · New Haven, CTNPI 1639598212

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 28.1% of the total. Reporting peaked in 2022 at $16,136 and has fallen 93.6% since, to $1,025 in 2025.

$38,637in general payments, 2019–2025

Across 233 payments — averaging $165.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$11K
  • Si-bone, Inc.$9K
  • Alphatec Spine, Inc$7K
  • Medtronic$7K
  • Globus Medical$2K
  • Johnson & Johnson$923
  • plus $2K from 7 others
$17,018in research payments, 2019–2025

Across 4 payments — averaging $4254.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bioventus LLC$17K

What the payments were for

  • Consulting fees$16,94644%
  • Travel & lodging$10,82028%
  • Food & beverage$10,80628%
  • Entertainment$660%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,637 in reported general payments places this provider in the 60th percentile of 25 orthopaedic surgery of the spine providers in Connecticut.

See all orthopaedic surgery of the spine providers in Connecticut

Medicare billing

Part B allowed, 2024
$41,339
Medicare patients
153
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam16$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →